Corcept Therapeutics logo

Key Account Manager (KAM) - Central Plains

Corcept Therapeutics

Any City, USRemotePosted 1 day ago$154,980 - $215,000
Full TimeSenior LevelCommercial & Pharma SalesPharmaceutical
Original posting ↗

Summary

The Key Account Manager is responsible for developing and executing institutional strategies to increase disease awareness, enhance system-level partnerships, and establish sustainable screening and identification pathways for hypercortisolism across targeted integrated delivery networks (IDNs), academic medical centers, and large healthcare systems.

Job description

KAMs engage a broad range of clinical and operational stakeholders including endocrinologists, diabetologists, cardiologists, neurosurgeons, endocrine surgeons, interventional radiologists, informatics leaders, quality teams, care coordination, population health, and senior system leadership.

Although the KAM role is part of Corcept’s Commercial organization, the role is not focused on branded promotion. Performance metrics, business objectives, and compensation are not tied to Korlym promotion or prescribing behavior. KAMs are not encouraged or incentivized to detail Korlym, promote prescribing, or discuss tactics intended to influence individual treatment decisions. Instead, the KAM role centers on disease education, institutional workflow alignment, and system change—not selling.

KAMs may provide accurate, balanced information about the FDA-approved use of Korlym when necessary to support system-level initiatives such as pathway development or EMR decision-support tools, while maintaining clear, compliant role boundaries.

The KAM works in deep collaboration with Clinical Specialists (CSs), Thought Leader Liaisons (TLLs), Medical Science Liaisons (MSLs), Market Access, Medical Affairs, Marketing, and Field Medical to ensure aligned, coordinated institutional strategy.

Responsibilities:

Execute Target Health System Strategy

  • Assess, map, and prioritize complex health system structures, workflows, and stakeholder networks
  • Build and maintain ongoing relationships with clinical, operational, administrative, and population health leaders
  • Establish consistent engagement cadence and long-term partnership plans for targeted institutions
  • Coordinate closely with cross-functional partners to ensure unified system execution

Accelerate System-Wide Disease Awareness

  • Conduct educational engagements with departments involved in screening, diagnosing, and managing complex metabolic diseases
  • Support system grand rounds, medical society events, internal conferences, and departmental education
  • Collaborate with TLLs and CSs to ensure accurate, cohesive dissemination of disease-state understanding across institutions

Drive Development of Hypercortisolism Identification Pathways

  • Identify key institutional stakeholders across informatics, quality, clinical operations, and specialty care to develop or enhance: Screening pathways, EMR flags and clinical decision-support tools, Order sets, Referral workflows, Multidisciplinary care pathways
  • Facilitate cross-department alignment to ensure operational feasibility and clinical adoption
  • Reinforce pathway use through ongoing education and system-wide implementation support

Korlym Education (when appropriate)

  • Provide accurate, balanced information on the FDA-approved use of Korlym to support system-level discussions such as workflow design or pathway planning
  • Maintain strict boundaries that prohibit: Promotional detailing, Sales messaging, Discussions intended to influence individual prescribing decisions
  • Triage HCP requests for prescribing information or product-related discussions to Clinical Specialists or MSLs per internal guidance

Optimize Cross-Functional Collaboration

  • Work seamlessly with CSs, TLLs, and MSLs as part of an integrated field approach to institutional engagement
  • Partner with Marketing, Medical Affairs, Market Access, Field Medical, and other teams to ensure strategic consistency
  • Share institutional insights, barriers, and opportunities to inform broader field strategy and resource development

Insights Generation & Strategic Communication

  • Capture high-quality, actionable institutional insights using approved systems and processes
  • Evaluate and synthesize trends such as workflow gaps, screening barriers, institutional priorities, or operational needs
  • Communicate insights effectively to internal teams to inform strategy, resource creation, and evidence-generation initiatives

Operational Excellence & Compliance

  • Maintain high standards in documentation, account planning, and CRM usage
  • Ensure alignment with internal policies, compliance requirements, and system expectations
  • Demonstrate professionalism, integrity, and consistency in all system interactions and field activities

Requirements

  • Strong understanding of health system dynamics, protocol design, clinical workflows, and multidisciplinary care coordination
  • Proven ability to influence development or adoption of pathways, EMR tools, or system-level processes
  • Strong insight-generation, analytical thinking, and strategic synthesis skills
  • Excellent communication skills across clinical and operational audiences
  • Ability to travel up to ~80% and maintain a driving record consistent with company policy
  • Bachelor’s degree preferred
  • 5+ years of pharmaceutical, biotech, or medical device experience, with demonstrated success engaging complex healthcare institutions
  • Experience in endocrinology, cardiometabolic disease, rare disease, or specialty therapeutic areas
  • Prior experience supporting clinical protocol adoption or workflow redesign
  • Applicants must be currently authorized to work in the United States on a full-time basis

Company overview

Corcept Therapeutics Inc. is a commercial-stage pharmaceutical company founded in 1998 and headquartered in Redwood City, California. The company specializes in the discovery, development, and commercialization of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effects of the hormone cortisol. Corcept's primary focus is on addressing the adverse effects of excess cortisol, which can lead to life-threatening conditions including Cushing's syndrome, various cancers, diabetes, and neurological disorders. The company's flagship product is Korlym (mifepristone), the first FDA-approved oral therapy for treating hyperglycemia in adult patients with endogenous Cushing's syndrome who have type 2 diabetes or glucose intolerance. With approximately 500 employees, Corcept has developed a large portfolio of proprietary compounds that selectively modulate cortisol effects without compromising progesterone function. The company maintains extensive intellectual property covering its selective cortisol modulators and continues to advance clinical trials for potential treatments of hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.